Many factors can affect lymphoma outlook, including the type, stage and spread of cancer, and a person's age and overall health. Read about lymphoma survival here.

Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new treatment options.

Stage 3 lymphoma is a lymphatic cancer that has spread to lymph nodes above and below the diaphragm. Learn its symptoms, ...

Treatments for non-Hodgkin lymphoma, a cancer of white blood cells, include chemotherapy, immunotherapy, radiation therapy, and stem cell transplants, with the specific approach depending on the ...

The study involves testing epcoritamab, administered subcutaneously, in combination with oral and intravenous anti-neoplastic agents. These include drugs like lenalidomide, ibrutinib, and polatuzumab ...

Antibody–Drug Conjugates for the Treatment of B-cell Non–Hodgkin's Lymphoma and Leukemia Yu-Waye Chu; Andrew Polson Disclosures Future Oncol. 2013;9 (3):355-368.

Large B-cell lymphomas (LBCL), composed predominantly of diffuse large B-cell lymphoma (DLBCL), are the most common type of non-Hodgkin lymphoma (NHL) that affect B-cell lymphocytes, a type of ...

Results from the Phase III KEYNOTE-689 trial show that adding perioperative Keytruda (pembrolizumab) to standard-of-care ...

Blood cancer, which originates from irregular blood cell generation within the bone marrow, represents a serious health ...

Volumetric PET biomarkers may help predict risk of toxicity from CAR T-cell therapy in patients with large B-cell lymphoma, ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

The first prediction tool of its kind for early-stage classic Hodgkin lymphoma provides estimates using continuous variables capturing nonlinear context.